12:33 :
Cadence Pharmaceuticals down 5.3% -
CHICAGO (MarketWatch) -- Shares of Cadence Pharmaceuticals Inc. were down 5.3% after the company said it would make an offering of 19 million shares for funding of its Ofirmev injectable acetaminophen, among other purposes. ...